2020-2025 Global Bronchodilators Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.
This report elaborates the market size, market characteristics, and market growth of the Bronchodilators industry, and breaks down according to the type, application, and consumption area of Bronchodilators. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Bronchodilators in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Bronchodilators market covered in Chapter 13:
Pulmagen Therapeutics
Boehringer Ingelheim
MediciNova
Pharmaxis
Regeneron Pharmaceuticals
Kyowa Hakko Kirin
Array BioPharma
Nycomed Pharma
GlaxoSmithKline
ASMACURE
Mundipharma International
Dynavax Technologies
ALK-Abello
Mitsubishi Tanabe Pharma
Kissei Pharmaceutical
AstraZeneca
Pearl Therapeutics
Atopix Therapeutics
Astellas Pharma
Oxagen
Amgen
CHIESI Farmaceutici
F. Hoffmann-La Roche

In Chapter 6, on the basis of types, the Bronchodilators market from 2015 to 2025 is primarily split into:
Anticholinergic bronchodilators
Adrenergic bronchodilators
Bronchodilator combinations
Methylxanthines

In Chapter 7, on the basis of applications, the Bronchodilators market from 2015 to 2025 covers:
Children
Adult

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025